The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Advances in pharmacogenomics: optimizing antiepileptic drug therapy for drug-resistant epilepsy”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2026 |
Maria Madalena Corrêa Melo, João Paulo Vilela Rodrigues, Luana Sueli Silva, Lincoln Marques Cavalcante Santos, Fabiana Rossi Varallo, Natália Valadares de Moraes, Leonardo Régis Leira Pereira. Association Between ABCB1 Gene Polymorphisms and DrugResistant Epilepsy: an Integrative Review, Brazilian Journal of Pharmaceutical Sciences. 2026; 62: e25063. https://doi.org/10.1590/s2175-97902026e25063 |
|
2 |
2025 |
Rania Magadmi, Pharmacogenetics of anti-seizure medications in Arab countries: a comprehensive review, Future Science OA. 2025; 11: 2528490. https://doi.org/10.1080/20565623.2025.2528490 |
|
3 |
2025 |
Rachda Riffi, Wefa Boughrara, Meriem Samia Aberkane, Wassila Ilias, Mohamed Sofiane Bouchetara, Amel Alioua Berrebbah, Fatma Belhoucine, Amina Chentouf. ABCB1 c.3435 C > T (rs1045642) as a biomarker for carbamazepine efficacy and toxicity in Algerian patients with epilepsy: initial findings report, Neurogenetics. 2025; 26: 29. https://doi.org/10.1007/s10048-025-00807-w |
|
4 |
2026 |
N. A. Shnayder, V. V. Bader, N. A. Pekarets, Yu. N. Bykov, A. M. Shirukova, R. F. Nasyrova. Pharmacogenomics and pharmacometabolomics of levetiracetam in personalized neurotoxicity risk assessment, Epilepsy and paroxysmal conditions. 2026; 18: 158. https://doi.org/10.17749/2077-8333/epi.par.con.2026.274 |